Therefore, by modulating the expression of mitochondrial fusion proteins such as MFN2 and OPA1, it is possible to improve mitochondrial function, promote mitophagy, alleviate oxidative stress and cellular senescence, and thus ameliorate the progression of COPD [57]. Here, OPA1 is linked to chronic obstructive pulmonary disease.